Back
Enliven Therapeutics Stock Price Chart
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Sell
29
ELVN
Enliven Therapeutics
Last Price:
24.13
Seasonality Move:
-7.59%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ELVN is experiencing slight selling pressure.
Enliven Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.13 | Sell |
| 20-day SMA: | 24.82 | Sell |
| 50-day SMA: | 26.73 | Sell |
| 200-day SMA: | 22.55 | Buy |
| 8-day EMA: | 24.29 | Sell |
| 20-day EMA: | 24.99 | Sell |
| 50-day EMA: | 25.55 | Sell |
| 200-day EMA: | 22.84 | Buy |
Enliven Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.75 | Sell |
| Relative Strength Index (14 RSI): | 41.67 | Sell |
| Chaikin Money Flow: | -36740 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.82 - 27.34) | Sell |
| Bollinger Bands (100): | (22.52 - 27.38) | Sell |
Enliven Therapeutics Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Enliven Therapeutics Stock
Is Enliven Therapeutics Stock a Buy?
- Enliven Therapeutics share price is 23.79 while ELVN 8-day simple moving average is 24.13, which is a Sell signal.
- The stock price of ELVN is 23.79 while Enliven Therapeutics 20-day SMA is 24.82, which makes it a Sell.
- Enliven Therapeutics 50-day simple moving average is 26.73 while ELVN share price is 23.79, making it a Sell technically.
- ELVN stock price is 23.79 and Enliven Therapeutics 200-day simple moving average is 22.55, creating a Buy signal.
ELVN Technical Analysis vs Fundamental Analysis
Sell
29
Enliven Therapeutics (ELVN)
is a Sell
Is Enliven Therapeutics a Buy or a Sell?
-
Enliven Therapeutics stock is rated a Sell
The current Enliven Therapeutics [ELVN] share price is $23.79. The Score for ELVN is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Enliven Therapeutics Stock Info
Market Cap:
1.16B
Price in USD:
23.79
Share Volume:
90.88K
Enliven Therapeutics 52-Week Range
52-Week High:
30.03
52-Week Low:
9.80
Sell
29
Enliven Therapeutics (ELVN)
is a Sell
Enliven Therapeutics Share Price Forecast
-
What is the Enliven Therapeutics stock price today?
The Enliven Therapeutics stock price is 23.79 USD today. -
Will ELVN stock go up or go down?
Enliven Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Enliven Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Enliven Therapeutics is overvalued.
Is Enliven Therapeutics Stock a Buy?
- Enliven Therapeutics share price is 23.79 while ELVN 8-day exponential moving average is 24.29, which is a Sell signal.
- The stock price of ELVN is 23.79 while Enliven Therapeutics 20-day EMA is 24.99, which makes it a Sell.
- Enliven Therapeutics 50-day exponential moving average is 25.55 while ELVN share price is 23.79, making it a Sell technically.
- ELVN stock price is 23.79 and Enliven Therapeutics 200-day simple moving average is 22.84, creating a Buy signal.
Fundamental Analysis of Enliven Therapeutics
Is Enliven Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.48 per share.
Technical Analysis of Enliven Therapeutics
Should I short Enliven Therapeutics stock?
- ELVN Moving Average Covergence Divergence (MACD) indicator is -0.75, suggesting Enliven Therapeutics is a Sell
- Enliven Therapeutics Relative Strength Index (RSI) is 41.67, which suggest Enliven Therapeutics is oversold
- The Bollinger Bands (25) for Enliven Therapeutics is (23.82 - 27.34), which suggest Enliven Therapeutics is a Sell
- The Bollinger Bands (100) for Enliven Therapeutics is (22.52 - 27.38), which suggest Enliven Therapeutics is a Sell
* Enliven Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.